መነሻ › አውቶኢሙን ሕመሞች › ሚኔሶታ
በሚኔሶታ ለአውቶኢሙን ሕመሞች የሚደረጉ ክሊኒካዊ ጥናቶች
ለአውቶኢሙን ሕመሞች የሚደረጉ 9 ጥናቶች በሚኔሶታ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በሚኔሶታ ውስጥ ያሉ ከተሞች
Official study text (English)
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- National Marrow Donor Program, Minneapolis
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ4 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT02579967RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Mayo Clinic - Accepting Adult Patients, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ ከ6 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Mayo Clinic: Division of Rheumatology, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07103746RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Minnesota, Minneapolis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06121297Abatacept for the Treatment of Giant Cell Arteritis
- Mayo Clinic, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT04474847RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Rochester, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06328777RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Mayo Clinic - Rochester, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT06359041A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Minnesota Medical School, Minneapolis
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- University of Minnesota Delaware Clinical Research Unit, Minneapolis
- Mayo Clinic, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ፌብሩ 2026 · NCT06626919ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።